Articles by Jill E. Sackman - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
Articles by Jill E. Sackman

Biotechnology Innovation and Growth in Israel

Israels diverse population, high-quality healthcare system, and resilience to global financial stress make it a strong partner for R&D, clinical research, and market growth.
Dec 2, 2013

Israel's diverse population, high-quality healthcare system, and resilience to global financial stress make it a strong partner for R&D, clinical research, and market growth.

Report from: Middle East and North Africa

The pharmaceutical industry grows despite conflict in the Middle East.
Oct 2, 2013

The pharmaceutical industry grows despite conflict in the Middle East.

Report from South Korea

The bio-pharmaceutical business outlook in South Korea remains positive.
Aug 2, 2013

The bio-pharmaceutical business outlook in South Korea remains positive.

Report from Southeast Asia

A unique demographic and payer mix make ASEAN an increasingly attractive region.
Jun 2, 2013

A unique demographic and payer mix make ASEAN an increasingly attractive region.

Report from Latin America

Latin America's diverse growing market seeks regulatory harmonization.
Apr 2, 2013

Latin America's diverse growing market seeks regulatory harmonization.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
29%
Oversee medical treatment of patients in the US.
10%
Provide treatment for patients globally.
6%
All of the above.
42%
No government involvement in patient treatment or drug development.
13%
Jim Miller Outsourcing Outlook Jim MillerCMO Industry Thins Out
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerFluorination Remains Key Challenge in API Synthesis
Marilyn E. Morris Guest EditorialMarilyn E. MorrisBolstering Graduate Education and Research Programs
Jill Wechsler Regulatory Watch Jill Wechsler Biopharma Manufacturers Respond to Ebola Crisis
Sean Milmo European Regulatory WatchSean MilmoHarmonizing Marketing Approval of Generic Drugs in Europe
FindPharma Custom Search
Click here